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Abstract
Background: This study was carried out to compare the HRQoL of patients in general practice
with differing chronic diseases with the HRQoL of patients without chronic conditions, to evaluate
the HRQoL of general practice patients in Germany compared with the HRQoL of the general
population, and to explore the influence of different chronic diseases on patients' HRQoL,
independently of the effects of multiple confounding variables.
Methods: A cross-sectional questionnaire survey including the SF-36, the EQ-5D and demographic
questions was conducted in 20 general practices in Germany. 1009 consecutive patients aged 15–
89 participated. The SF-36 scale scores of general practice patients with differing chronic diseases
were compared with those of patients without chronic conditions. Differences in the SF-36 scale/
summary scores and proportions in the EQ-5D dimensions between patients and the general
population were analyzed. Independent effects of chronic conditions and demographic variables on
the HRQoL were analyzed using multivariable linear regression and polynomial regression models.
Results: The HRQoL for general practice patients with differing chronic diseases tended to show
more physical than mental health impairments compared with the reference group of patients
without. Patients in general practice in Germany had considerably lower SF-36 scores than the
general population (P < 0.001 for all) and showed significantly higher proportions of problems in all
EQ-5D dimensions except for the self-care dimension (P < 0.001 for all). The mean EQ VAS for
general practice patients was lower than that for the general population (69.2 versus 77.4, P <
0.001). The HRQoL for general practice patients in Germany seemed to be more strongly affected
by diseases like depression, back pain, OA of the knee, and cancer than by hypertension and
diabetes.
Conclusion: General practice patients with differing chronic diseases in Germany had impaired
quality of life, especially in terms of physical health. The independent impacts on the HRQoL were
different depending on the type of chronic disease. Findings from this study might help health
professionals to concern more influential diseases in primary care from the patient's perspective.
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Background
Primary care addresses the most common problems in the
community by providing preventive, curative, and reha-
bilitative services to maximize health and well-being [1].
"The Ecology of Medical Care Revisited," by Green et al.
[2] provided a broader, still useful framework for thinking
about the organization of health care, medical education,
and research originally developed by White et al. [3]. The
"ecology" implies that patients who are seen in primary
care are a special population, differing both from the gen-
eral population and patient populations in a secondary
care setting. Health information related to patients out-
side primary care is not comparable to patients in this set-
ting [4].
Health-related quality of life (HRQoL), representing peo-
ple's subjective assessment of their sense of well-being
and ability to perform social roles, has been well accepted
as a health indicator in medical interventions or health
surveys. The HRQoL of patients with one single chronic
disease has been explored in primary care [5-7]. For exam-
ple, the quality of life of patients with prolonged back
pain was significantly worse than that of the average Finn
[5]. The mean HRQoL score of patients with an untreated
depression at baseline was quite low. Eight percent of
patients rated their health state as worse than death [6]. In
another study, newly diagnosed patients with Type 2 dia-
betes in general practice compared with screening-
detected patients reported more diabetes-related symp-
tom distress shortly after the diagnosis, and a consistently
worse mental health status at 6 months and 12 months
[7]. However, most studies on the HRQoL of patients with
chronic diseases in the primary care setting are focused on
one chronic disease in particular. Relatively little is known
about HRQoL profiles for primary care patients with dif-
fering chronic diseases, and the differences in HRQoL for
primary care patients in comparison to the general popu-
lation [8]. Even if a substantial percentage of chronically
ill patients suffers from more than one chronic condition,
or multimorbidity in this setting [9,10], a small number
of studies focused on the relationship between multimor-
bidity and HRQoL [11], or the combined effects of pairs
of chronic diseases on the HRQoL [8,12]. Systematic
investigations into the independent influence of the mul-
tiple chronic diseases in primary care are still limited.
In the current study, we compared the HRQoL of patients
in general practice with differing chronic diseases with the
HRQoL of patients without chronic conditions. We evalu-
ated the HRQoL profiles of consecutive patients present-
ing for general practice consultation in Germany and
compared them with those of the general population.
Finally, we tried to estimate the effect of each chronic dis-
ease independently of the effects of multiple confounding
variables.
Methods
Setting
A cross-sectional survey was conducted in 20 general prac-
tices from the regional mailing list of the Institute of Gen-
eral Practice, University Hospital Schleswig-Holstein
between June and December 2002. Each practice was
asked to complete 50 questionnaires. Several large prac-
tices were ready to include more patients.
Study population
On given days chosen by each practice, all consecutive
patients over 14 years old were invited to self-administer
the survey before consultation. Each participant put the
completed questionnaire into an anonymous envelope
and gave it to his or her doctor. For each patient, the doc-
tor recorded up to three diagnoses for the actual encoun-
ter and three existing chronic conditions or major health
problems. The protocol was approved by University Hos-
pital Schleswig-Holstein Ethics Committee and all sub-
jects provided informed consent.
Questionnaire
The Medical Outcomes Study 36-item Short Form Health Sur-
vey (SF-36), consists of 36 items which measure eight
scales: physical functioning (PF), role limitations due to
physical problems (RP), bodily pain (BP), general health
(GH), vitality (VT), social functioning (SF), role limita-
tions due to emotional problems (RE), and mental health
(MH). On the basis of these separate subscales, compo-
nent summary scores can be calculated to provide a global
measure of physical (Physical Component Summary
score, PCS) and mental functioning (Mental Component
Summary score, MCS), respectively. The scale scores range
from 0 to 100, with higher scores indicating a better
health status. The PCS and MCS have been standardized
on the basis of a normative US general population data
set, with the mean set at 50 (SD 10) [13].
The EQ-5D questionnaire is a simple generic HRQoL instru-
ment. It comprises two pages: on the first page respond-
ents record the extent of their problems in each of five
dimensions (self-classifier) concerning mobility, self-care,
usual activities, pain/discomfort, and anxiety/depression;
on the second page, they record their perception of overall
health on a visual analogue scale (EQ VAS). EQ VAS scores
may range between 0 (worst imaginable health) and 100
(best imaginable health) [14].
Besides HRQoL instruments, demographic questions
were included in the questionnaire. These variables
included age, gender, marital status, employment status,
smoking, educational attainment (high school or more/
having a professional certificate), academic degree or
qualification, medical insurance, and self-reported severe
illness experience.BMC Public Health 2008, 8:246 http://www.biomedcentral.com/1471-2458/8/246
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Statistical methods
The diagnoses and morbidity data were coded according
to the International Classification of Primary Care (ICPC-
2) [15]. Thirteen chronic diseases were extracted from the
codes: hypertension, diabetes, asthma or chronic obstruc-
tive pulmonary disease (COPD), heart disease of any
kind, stroke, osteoarthritis (OA) of the knee, other joint
diseases, depression, cancer, chronic back pain, polyar-
thritis, other mental illness, and migraine. Multimorbid-
ity was defined as reporting two or more health problems
of the selected thirteen chronic diseases.
The SF-36 scores were calculated according to the estab-
lished scoring algorithms for the German version of the
SF-36 [16]. The disease groups were partly overlapping
because of multimorbidity, so it was not possible to com-
pare across groups. Instead, unadjusted SF-36 scale scores
of each disease group were compared with those of the ref-
erence group without any of the thirteen chronic condi-
tions. The original response choices in the EQ-5D self-
classifier (no problem, some/moderate problems, and
extreme/unable to) were regrouped into two categories
(reporting no problem and reporting any problem). As
well, the proportions reporting any problem for each dis-
ease group were compared with those for the reference
group by means of the chi-square test.
The eight SF-36 scale and two summary scores of patients
in general practice were compared with the general popu-
lation in Germany [17]. Both parametric t test and non-
parametric Mann-Whitney U test were used to allow the
comparison of results, allowing for the possibility that the
data might not match normal distribution. The propor-
tions reporting any problem in the EQ-5D dimensions for
each disease group were compared with those for the gen-
eral population [18] using the chi-square test. The mean
EQ VAS for general practice patients was compared with
those for the general population using the t test. The EQ
index derived from the responses to the five dimensions
was not analyzed in this paper, because we think the index
is conventionalized and can be regarded as a societal val-
uation of the respondent's health state, not the respond-
ent's own assessment of his or her health state.
The independent effects of differing chronic diseases, self-
reported severe illness experience, age, gender, marital sta-
tus, employment status, smoking, education attainment
(high school or more/having a professional certificate),
academic degree or qualification, and medical insurance
on the PCS and MCS scores of the SF-36 and EQ VAS score
were analyzed using multivariable linear regression (Vari-
able selection procedure: Enter). Additional regression
analyses explored the possibility of non-linear relation-
ships between age as a continuous variable and the PCS
and MCS scores of the SF-36 and EQ VAS score. We also
examined interactions between age and chronic diseases.
All statistical analyses were carried out using SPSS for Win-
dows (version 13.0; SPSS Inc., Chicago, IL, USA).
Results
Of the 1231 patients recruited by 20 practices, 1041
agreed to participate, representing a response rate of
84.6%. Twenty-four questionnaires were deleted because
diagnoses were missing (in one practice). Eight other
questionnaires were completed by accompanying persons
and therefore excluded.
Among the 1009 eligible respondents, 61.4% were
women, and the mean age was 48.5 years (range 15–89,
SD 17.4). A total of 428 (42.4%) respondents did not
have any of the selected chronic diseases, 377(37.4%) had
one, 155 (15.4%) had two, and 49 (4.9%) had three or
more of the diseases. More than one third (35.1%) of
patients with the selected chronic diseases had at least one
other chronic disease. The 190 non-respondents had a
mean age of 57.0 years (range 14–91, SD 18.6). A total of
176 non-respondents reported the reasons why they
refused to participate. Thirty-two percent of them attrib-
uted their refusal to visual or comprehension problems.
The demographic characteristics of the sample are shown
in Table 1. Patients with chronic diseases were more likely
than the reference group to be older, unemployed, and
less educated.
Table 2 compares the unadjusted SF-36 scale scores of
patients with each chronic disease with those of the refer-
ence group. Stroke was removed from the subsequent
analysis because only three patients were in this group.
Overall, significant differences between all disease groups
and the reference group existed except for other mental ill-
ness and migraine. Patients in each disease group had one
or more lower SF-36 scale scores than those in the refer-
ence group. The SF, RE, and MH scale scores evaluating
mental health were significantly lower only for patients
with depression and other mental illness. In depression
patients, to note, all eight scale scores were significantly
lower.
Complete data in all EQ-5D dimensions were only avail-
able for 914 respondents. A total of 707 (77.4%) of
respondents reported problems in one or more of the EQ-
5D dimensions. Pain/discomfort was the dimension most
frequently (68.7%) noted as causing problems. (Figure 1).
A total of 830 respondents gave answers in the EQ VAS
score with a mean of 69.2 (range 0–100, SD 19.8). Table
3 compares the unadjusted proportions reporting any
problems in the EQ-5D self-classifier for each disease
group, with those for the reference group. The presence ofBMC Public Health 2008, 8:246 http://www.biomedcentral.com/1471-2458/8/246
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Table 1: Demographic characteristics of general practice patients by disease groups
Mean age (SD) Female (%) Now married 
(%)
Employed or 
self-employed 
(%)
Having high school 
or more education 
or a professional 
certificate (%)
Having an 
academic degree 
or qualification 
(%)
Statutory 
insurance (%)
Overall
(n = 1009)
48.5 (17.4) 61.4 62.8 50.8 83.4 24.0 87.6
Reference 
group
(n = 428)
40.5 (15.8) 65.2 58.6 59.6 87.3 23.2 86.9
Hypertension
(n = 217)
61.5 (13.2) 54.1 68.5 35.5 77.9 26.5 86.8
Diabetes
(n = 78)
63.0 (12.1) 47.1 73.5 29.9 70.6 21.7 88.2
Asthma/COPD
(n = 54)
52.1 (18.5) 57.1 56.3 36.0 81.6 31.9 86.0
Heart disease
(n = 78)
64.8 (15.7) 50.7 60.6 20.8 72.2 25.8 89.0
Stroke
(n = 3)
55.5 (23.3) 66.7 66.7 0 50 0 100
OA knee
(n = 17)
67.8 (8.0) 52.9 82.4 11.8 52.9 5.9 76.5
Other joint 
diseases
(n = 30)
61.7 (14.6) 48.0 65.4 34.6 73.1 25.0 80.8
Depression
(n = 63)
52.2 (17.6) 83.0 50.0 47.4 80.7 17.6 91.1
Cancer
(n = 38)
58.8 (13.3) 72.4 71.9 35.5 78.1 19.4 96.9
Back pain
(n = 193)
51.1 (15.2) 58.1 67.5 53.8 82.2 26.8 88.2
Polyarthritis
(n = 13)
55.6 (15.3) 75.0 76.9 38.5 61.5 0 84.6
Other mental 
illness
(n = 29)
43.4 (14.3) 65.2 34.8 60.9 82.6 36.4 91.3
Migraine
(n = 25)
42.0 (12.1) 90.5 63.6 68.2 90.9 22.7 95.5
Table 2: Mean SF-36 scale scores for general practice patients by disease groups
PF RP BP GH VT SF RE MH
Reference group (n = 428) 82.8 69.1 68.6 64.0 54.1 77.7 72.6 67.0
Hypertension2 ** (n = 217) 71.5*** 58.4** 62.9** 56.3*** 56.8 79.2 77.8 72.4*
Diabetes2 ** (n = 78) 66.5*** 56.7* 62.4 58.0** 59.1* 80.4 80.4* 75.1**
Asthma/COPD1 *** (n = 54) 68.1*** 42.7*** 59.5* 47.4*** 47.7* 73.8 71.4 66.4
Heart disease1 *** (n = 78) 59.7*** 44.2*** 57.2** 49.7*** 46.9* 74.7 61.7 67.4
OA knee1 *** (n = 17) 62.7** 46.7** 48.8** 53.0* 57.7 80.2 89.6* 72.6
Other joint diseases1 * (n = 30) 63.4** 48.2* 47.4** 56.1 51.1 75.8 69.1 65.8
Depression2 ** (n = 63) 68.3*** 48.9** 55.5** 54.0*** 39.2*** 59.0*** 39.6*** 46.6***
Cancer1 * (n = 38) 66.6** 49.2 58.6 51.8** 52.0 71.3 63.6 63.5
Back pain1 *** (n = 193) 72.2*** 52.7*** 49.7*** 58.4** 51.8 76.5 70.9 67.2
Polyarthritis1 * (n = 13) 57.8*** 46.2* 46.8** 46.6* 47.9 70.2 55.6 63.3
Other mental illness1 (n = 29) 80.9 61.0 69.0 54.1 47.0* 66.1 53.8* 56.9*
Migraine1 (n = 25) 78.9 60.9 55.1* 60.5 49.2 75.5 84.1 68.7
PF: physical functioning; RP: role physical; BP: bodily pain; GH: general health; VT: vitality; SF: social functioning; RE: role emotional; MH: mental 
health. * P < 0.05, ** P < 0.01, *** P < 0.001 1. Multivariate Analysis of Variance (Hotelling T2) for groups with equal covariance matrices: there were 
significant differences between all these disease groups and the reference group except other mental illness and migraine groups. 2. Mann-Whitney 
U test with Bonferroni correction for groups with unequal covariance matrices: there were significant differences between these disease groups and 
the reference group.BMC Public Health 2008, 8:246 http://www.biomedcentral.com/1471-2458/8/246
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any chronic disease tended to increase the risk of report-
ing any problem in at least one dimension. Similarly, the
proportions reporting any problem in the dimension of
anxiety/depression were significantly higher only for
patients with depression and other mental illness.
The comparison of the SF-36 scores for general practice
patients and for the general population is shown in Table
4, Figure 2. Both parametric and non-parametric methods
gave virtually identical results. Patients in general practice
had a significantly lower score in each scale or summary
score (P < 0.001 for all). The differences observed in the
scales concerning daily role limitations (RP and RE) were
particularly salient. Table 5 shows the difference in the
proportion of respondents reporting any problem in the
EQ-5D self-classifier between general practice patients
and the general population. The proportions of general
practice patients reporting any  problems were signifi-
cantly higher (P < 0.001 for all) than those of the general
population in all dimensions except for the self-care
dimension. The mean EQ VAS for general practice patients
was lower than that for the general population (69.2 ver-
sus 77.4, P < 0.001).
Multivariable linear regression showed that OA of the
knee, back pain, experience of own illness, old age, having
never married, and seeking work were significant predic-
tors of a lower SF-36 PCS score. Depression, experience of
own illness and divorced/separated were significant risk
factors, and back pain was a significant mitigating factor
in the regression equation for the SF-36 MCS score.
Depression, cancer, experience of own illness, and having
never married were significant risk predictors of the EQ
VAS score, while patients with more education tended to
have a higher score (Table 6). The residuals from the lin-
ear regression models approximated a normal distribu-
tion.
Table 7 shows the results of polynomial regression analy-
ses using age in years, age squared, and age cubed. The
non-linear association between age and the MCS and EQ
VAS score were statistically significant (P  < 0.05). The
Distribution of the EQ-5D self-classified health states of patients in German general practice Figure 1
Distribution of the EQ-5D self-classified health states of patients in German general practice.
0%
20%
40%
60%
80%
100%
no problem some problems extreme problems
extreme problems 0.1 0.3 1.9 7.4 2.9
some problems 24.4 3.1 31.4 61.3 34.1
no problem 75.5 96.6 66.7 31.3 63
mobility self-care usual activity pain/ discomfort
anxiety/
depressionBMC Public Health 2008, 8:246 http://www.biomedcentral.com/1471-2458/8/246
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MCS score tends to decrease during the initial period of
getting old, and then begins to increase. The EQ VAS score
tends to have the inverse order. The relationships between
age and the PCS score were considered to be linear associ-
ation. The joint effects on the SF-36 PCS score between
age and hypertension were less negative due to the posi-
tive interaction effect (P  < 0.05). Interaction effects
between age and all other chronic diseases were not statis-
tically significant.
Discussion
In this study, we found that general practice patients with
chronic diseases seemed to have an impaired quality of
life, compared with patients without any of the selected
chronic conditions in a consecutive sample in Germany.
Except for psychiatric disorders, these impairments were
greater in physical functioning than in mental health. We
also found that general practice patients in Germany had
considerably lower scale scores and component summary
scores for the SF-36 and higher proportions reporting any
problems in all EQ-5D dimensions except for the self-care
dimension, compared with the general population.
Finally when we controlled for demographic variables
such as age, gender, marital status, employment status,
smoking, educational attainment, academic degree or
qualification, medical insurance, and self-reported severe
illness experience, we found that OA of the knee and back
pain predicted of a lower SF-36 PCS score, depression pre-
dicted of a lower SF-36 MCS score, and that depression
and cancer were risk factors for the EQ VAS score.
Twenty percent of consecutive patients visiting the general
practice had more than one of the thirteen chronic dis-
eases. The proportion of multimorbidity (two or more
medical conditions) in general practice patients varied in
previous studies: e.g. 3.6% [19], 16.2% [4] and 29.7% [9]
of the population under study, which can be explained by
the narrow, medium, or broad nosological spectrum
respectively. Studies included only patients visiting the
general practice during the study period might report a
higher overall prevalence of multimorbidity than those
where all patients registered in general practice were con-
cerned [9]. It is difficult to compare these studies because
of many differences in methodology, target population,
and the number and type of diseases under study.
Based on the results of univariate analysis, patients with
chronic diseases seemed to have a lower quality of life,
Table 3: The likelihood of reporting any problem in the EQ-5D self-classifier by disease groups
Number (proportion) of respondents reporting any problem
Mobility Self-care Usual activity Pain/discomfort Anxiety/depression
Reference group (n = 428) 83(20.0%) 10(2.4%) 120(29.0%) 248(60.2%) 149(35.8%)
Hypertension (n = 217) 49(25.5%) 7(3.6%) 48(25.4%) 134(70.2%)* 54(28.4%)
RR (95% CI) 1.27(0.94–1.73) 1.51(0.58–3.90) 0.88 (0.66–1.17) 1.17 (1.03–1.32) 0.79 (0.61–1.03)
Diabetes (n = 78) 24(34.8%)** 2(3.0%) 17(25.0%) 45(65.2%) 20(29.0%)
RR (95% CI) 1.74(1.19–2.53) 1.23(0.28–5.50) 0.86(0.56–1.34) 1.08(0.90–1.31) 0.81(0.55–1.20)
Asthma/COPD (n = 54) 18(36.0%)* 4(8.0%) 23(46.0%)* 39(78.0%)* 21(42.9%)
RR (95% CI) 1.80(1.18–2.72) 3.30(1.08–10.14) 1.59(1.13–2.22) 1.30 (1.10–1.53) 1.20(0.84–1.70)
Heart disease (n = 78) 21(31.3%)* 3(4.5%) 25(37.9%) 49(75.4%)* 20(29.9%)
RR (95% CI) 1.56(1.04–2.34) 1.85(0.52–6.55) 1.31(0.93–1.84) 1.25(1.07–1.47) 0.83(0.56–1.23)
OA knee (n = 17) 9(56.3%)** 1(6.3%) 6(37.5%) 16(94.1%)** 6(35.3%)
RR(95% CI) 2.81(1.75–4.50) 2.58(0.35–18.96) 1.29(0.68–2.48) 1.56(1.36–1.80) 0.98(0.51–1.90)
Other joint diseases (n = 30) 9(36.0%) 2(8.3%) 9(37.5%) 21(84.0%)* 9(36.0%)
RR (95% CI) 1.80(1.03–3.13) 3.44(0.80–14.84) 1.29(0.76–2.22) 1.40(1.16–1.68) 1.00(0.59–1.72)
Depression (n = 63) 17(30.4%) 1(1.8%) 26(47.3%)** 41(75.9%)* 45(83.3%)***
RR (95% CI) 1.51(0.97–2.35) 0.74(0.10–5.65) 1.63(1.19–2.24) 1.26(1.06–1.49) 2.33(1.95–2.77)
Cancer (n = 38) 11(31.4%) 0(0%) 19(54.3%)** 26(74.3%) 16(47.1%)
RR (95% CI) 1.57(0.93–2.65) - (-) 1.87(1.33–2.63) 1.23(1.00–1.52) 1.31(0.90–1.92)
Back pain (n = 193) 50(28.4%)* 8(4.6%) 73(41.2%)** 146(83.4%)*** 61(34.7%)
RR (95% CI) 1.42(1.05–1.92) 1.90(0.76–4.73) 1.42(1.13–1.79) 1.39(1.25–1.54) 0.97(0.76–1.23)
Polyarthritis (n = 13) 4(30.8%) 1(7.7%) 5(38.5%) 13(100%)** 7(53.8%)
RR (95% CI) 1.54(0.66–3.55) 3.18 (0.44–23.01) 1.33 (0.66–2.68) 1.66 (1.54–1.80) 1.50 (0.89–2.53)
Other mental illness (n = 29) 3(11.1%) 1(3.6%) 13(48.1%)* 20(71.4%) 17(63.0%)**
RR(95% CI) 0.55(0.19–1.64) 1.48(0.20–11.12) 1.66(1.09–2.53) 1.19(0.93–1.52) 1.76(1.28–2.41)
Migraine (n = 25) 7(29.2%) 0(0%) 5(20.8%) 20(83.3%)* 6(25.0%)
RR (95% CI) 1.46(0.76–2.79) -(-) 0.72(0.32–1.59) 1.38(1.14–1.68) 0.70(0.34–1.41)
* P < 0.05, ** P < 0.01, *** P < 0.001 by chi-square tests on the difference in the proportion of respondents reporting any problem between 
patients with the selected chronic diseases and the reference group, df = 1. RR = the relative risk of reporting any problem of respondents with the 
selected chronic diseases compared with the reference group.BMC Public Health 2008, 8:246 http://www.biomedcentral.com/1471-2458/8/246
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compared with patients without any of the thirteen
chronic conditions. Except for psychiatric disorders, these
impairments were, as expected, stronger for dimensions of
physical health than for dimensions of mental health.
Patients with depression experienced both physical and
mental health impairments significantly. Patients with
hypertension and diabetes experienced better mental
health than the reference group. Similar results were
described in other studies [4,20-22]. However, some of
the observed effects might reflect the combined result of
the disease, comorbid conditions and demographics. In
the multivariable regression models of our data, depres-
sion significantly impaired the SF-36 MCS score, while
back pain affected mental health positively and other
chronic diseases were "neutral". Rijken et al. assessed the
separate and joint effects of cardiovascular disease, cancer,
arthritis, chronic respiratory disease, diabetes mellitus,
and thyroid dysfunction. They found physical functioning
appeared to be impaired in all six diagnostic groups,
whereas mental functioning was more or less comparable
with reference data for the general population [12].
Increased multimorbidity was also found to be more
strongly associated with a greater deterioration in physical
functioning than in mental health in two other studies
[23,24].
Quality of life rating is subjective and relative to a person's
life expectations [25]. Patients suffering from chronic dis-
ease over a long period of time may become used to their
illness. An important mediator of this psychological adap-
tation process is "response shift", which involves chang-
ing internal standards, values and the conceptualization
of HRQoL [26,27]. Patients of advanced age and with
chronic diseases might downscale their expectations for
life and feel contented as long as they could stabilize their
condition and be free from complications. As our results
showed, old patients had better mental health, and ageing
patients suffering from hypertension report less physical
disability than could be expected from the separate effects
of these two influential factors. Even though many
Table 4: Comparison of the SF-36 scale and summary scores of general practice patients and those of the general population in 
Germany [17]
Mean (SD) t1 PM e d i a n  ( I R ) Z2 P
PF
General practice patients 76.2(25.0) 85.0(34.7)
General population 85.8(20.4) 11.56 <0.001 95.0(20.0) -13.94 <0.001
RP
General practice patients 61.7(41.9) 75.0(75.0)
General population 82.8(32.4) 14.74 <0.001 100(25.0) -16.93 <0.001
BP
General practice patients 62.7(28.8) 62.0(59.0)
General population 67.7(25.9) 5.11 <0.001 72.0(49.0) -4.56 <0.001
GH
General practice patients 59.7(19.1) 62.0(27.0)
General population 66.5(18.2) 10.32 <0.001 67.0(27.0) -10.42 <0.001
VT
General practice patients 52.9(20.0) 55.0(30.0)
General population 60.3(17.8) 10.85 <0.001 60.0(25.0) -10.73 <0.001
SF
General practice patients 76.3(24.5) 87.5(37.5)
General population 86.8(19.6) 12.81 <0.001 100(25.0) -14.38 <0.001
RE
General practice patients 71.1(40.2) 100(66.7)
General population 89.4(26.5) 13.42 <0.001 100(0) -16.81 <0.001
MH
General practice patients 66.8(19.4) 68.0(31.2)
General population 72.6(16.6) 8.90 <0.001 76.0(20.0) -8.64 <0.001
PCS
General practice patients 45.2(11.1) 47.3(16.7)
General population 48.5(9.3) 8.43 <0.001 51.0(10.9) -8.82 <0.001
MCS
General practice patients 46.9(11.8) 49.8(17.2)
General population 51.0(8.7) 9.82 <0.001 53.0(9.6) -8.79 <0.001
PF: physical functioning; RP: role physical; BP: bodily pain; GH: general health; VT: vitality; SF: social functioning; RE: role emotional; MH: mental 
health; PCS: physical component summary score; MCS: mental component summary score.
1.t test. 2. Mann-Whitney U test.BMC Public Health 2008, 8:246 http://www.biomedcentral.com/1471-2458/8/246
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chronic diseases often result in life-threatening complica-
tions and reduce life expectancy, these adverse events are
typically preceded by many "silent" years. Asymptomatic
status may be less likely to affect quality of life.
The clinically important difference (CID) reflects the
amount of change (either improvement or decline) in
HRQoL that is meaningful to patients and/or their health
care providers [28]. The CID estimates for the patient-
reported outcome measures depend on the rater and
assessment methodology and may potentially vary for dif-
ferent questionnaires, different population and context.
Published research indicates that a difference of 2.5–5
points in SF-36 PCS or MCS scores and 5–10 points in SF-
36 scale scores among rheumatoid arthritis patients is
considered clinically important [29,30]. The CIDs for the
SF-36 scales established by the heart disease expert panel
were generally greater than the CIDs agreed on by the
asthma and COPD panels, and were all greater than the
CID thresholds developed among patients with rheuma-
toid arthritis [31]. However, there is some evidence of
commonality in the variety of approaches. For example,
The SF-36 scale scores for patients in general practice and those for the general population in Germany Figure 2
The SF-36 scale scores for patients in general practice and those for the general population in Germany.
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Table 5: Percentage of patients and the general population with problems in the EQ-5D self-classifier [18]
General practice patients General population
Moderate problems Extreme problems Moderate/extreme problems Moderate/extreme problems
Mobility 24.4 0.1 24.5 17***
Self-care 3.1 0.3 3.4 3
Usual activity 31.4 1.9 33.3 10***
Pain/discomfort 61.3 7.4 68.7 28***
Anxiety/depression 34.1 2.9 37.0 4***
* P < 0.05, ** P < 0.01, *** P < 0.001 by chi-square tests on the difference in the proportion of respondents reporting any problem between general 
practice patients and the general population, df = 1.BMC Public Health 2008, 8:246 http://www.biomedcentral.com/1471-2458/8/246
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Table 6: Multivariable regression models for the SF-36 summary scores and the EQ VAS score versus chronic diseases and 
demographic characteristics
Variable PCSa MCSb EQ VASc
βd(SE)e P value βd(SE)e P value βd(SE)e P value
Chronic diseases
Hypertension -1.131(1.457) 0.438 2.613(1.696) 0.124 1.279(2.871) 0.656
Diabetes -1.282(2.297) 0.577 5.236(2.674) 0.051 6.196(4.523) 0.172
Asthma/COPD -4.299(2.370) 0.070 -0.394(2.758) 0.886 -8.833(4.997) 0.078
Heart disease -2.994(2.193) 0.173 -0.135(2.553) 0.958 -2.077(4.492) 0.644
OA knee -11.009(4.092) 0.007 8.918(4.763) 0.062 0.315(9.433) 0.973
Other joint diseases -5.339(3.339) 0.111 -0.260(3.886) 0.947 -8.303(7.007) 0.237
Depression -1.255(2.197) 0.568 -8.664(2.557) 0.001 -11.222(4.460) 0.012
Cancer -1.912(2.994) 0.523 -0.936(3.485) 0.788 -16.312(5.845) 0.006
Back pain -5.126(1.332) <0.001 3.322(1.550) 0.033 0.089(2.688) 0.974
Polyarthritis -6.960(4.046) 0.086 5.458(4.710) 0.247 -7.721(8.817) 0.382
Other mental illness 2.586(3.297) 0.433 -6.999(3.838) 0.069 -6.841(6.174) 0.269
Migraine -2.616(3.120) 0.402 1.364(3.631) 0.707 4.457(6.830) 0.514
Demographic characteristics
Self-illness -3.001(1.120) 0.008 -5.566(1.304) <0.001 -6.913(2.256) 0.002
Illness-family members -1.568(1.166) 0.179 1.545(1.357) 0.255 1.098(2.351) 0.641
Gender 0.654(1.124) 0.561 -1.545(1.308) 0.238 -2.450(2.223) 0.271
Age -0.118(0.057) 0.039 0.065(0.067) 0.328 -0.004(0.114) 0.973
High school or more education or a professional certificate 2.153(1.608) 0.181 2.254(1.872) 0.229 6.737(3.337) 0.044
Academic degree or qualification 0.654(1.184) 0.581 -0.251(1.378) 0.856 -1.449(2.389) 0.544
Marital status (now married as reference)
Never married -3.923(1.455) 0.007 -1.603(1.693) 0.345 -5.557(2.805) 0.048
Widowed -4.316(2.395) 0.072 2.474(2.787) 0.375 -7.208(4.972) 0.148
Divorced/separated 0.403(2.046) 0.844 -7.951(2.382) 0.001 -5.603(4.062) 0.169
Smoke(no smoker as reference)
Smoker -1.632(1.224) 0.183 -0.518(1.425) 0.716 -3.372(2.468) 0.173
Ex-smoker -1.249(1.206) 0.301 -0.966(1.403) 0.492 -3.357(2.407) 0.164
Employment (employed or self-employed as reference)
Retired -0.531(2.004) 0.791 0.021(2.333) 0.993 -6.745(3.881) 0.083
Keeping house -2.283(1.649) 0.167 -0.065(1.919) 0.973 0.552(3.359) 0.869
Student 1.699(1.927) 0.378 -1.632(2.242) 0.467 2.514(3.798) 0.508
Seeking work -6.156(2.686) 0.022 0.218(3.127) 0.945 -9.265(5.160) 0.073
Other 3.958(9.594) 0.680 3.817(11.167) 0.733 4.144(18.964) 0.827
Medical insurance (statutory medical insurance as reference)
Commercial medical insurance 0.005(1.464) 0.997 1.996(1.704) 0.242 0.943(2.965) 0.751
Other 2.402(3.243) 0.459 0.181(3.774) 0.962 -4.325(6.417) 0.501
Constant 56.343(3.229) <0.001 43.542(3.759) <0.001 74.474(6.480) <0.001
F value 4.292 <0.001 3.247 <0.001 2.565 <0.001
R-square 0.256 0.207 0.175
a PCS: physical component summary score.
b MCS: mental component summary score.
c EQ VAS: EQ-5D visual analogue scale.
d Regression coefficient (linear relationship).
e SE = standard error.BMC Public Health 2008, 8:246 http://www.biomedcentral.com/1471-2458/8/246
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the estimates of the CID for the SF-6D and EQ-5D appear
to be proportionally equivalent in the context of the range
of utility scores for each scale [32]. In most circumstances,
half a SD may serve as a default value for important
patient-perceived change on HRQoL measures used with
chronic disease patients in the absence of more specific
information [33]. In the present study, the differences
observed in the SF-36 scales concerning daily role limita-
tions (RP and RE) and social functioning (SF) between
general practice patients and the general population
exceeded the value of 0.5 SD. This might help general
practitioner initially evaluate and treat their patients.
The HRQoL for patients was measured with generic
HRQoL measurements, the SF-36 and EQ-5D. Both the
SF-36 and EQ-5D are applicable to a wide range of health
conditions, which are suitable for the primary care setting.
The SF-36 measures health status over the past four weeks
and the EQ-5D measures health status on the day. The
advantages of the SF-36 include its broader coverage of
HRQoL dimensions (health profiles) [13], while the
advantages of the EQ-5D include its brevity and simplic-
ity, comparability across different populations, as well as
its applicability in health-economic evaluations (prefer-
ence-based measures) [14]. Correlations between SF-36
subscale scores and EQ dimensions were reported to be
no more than 0.50 (considered to be a high correlation by
Cohen [34]), except for the correlations between bodily
pain (SF-36) and pain/discomfort (EQ-5D) (0.57) and
mental health (SF-36) and anxiety/depression (EQ-5D)
(0.50) [35]. Because of the limited number of responses
(3) in each of the EQ dimensions (5), a ceiling effect may
occur when measuring health among a relatively healthy
population [18,35]. We expected the measurement of
HRQoL using both the SF-36 and EQ-5D to present more
meaningful information than only one of the forms
alone, due to their different measurement attributes. Our
investigation showed that both instruments reported
impairments in comparable scales or dimensions for
patients with any chronic disease, compared with the ref-
erence group. Neither of them reported impairments in
facets of mental status for patients with any chronic dis-
ease except for patients with depression and other mental
illness. Even though the two metrics are both intended to
capture HRQoL, they seem to capture different aspects of
it. For example, OA of the knee and back pain were signif-
icant predictors of lower SF-36 PCS but none of these were
significant predictors of the EQ VAS score, while depres-
sion and cancer were significant predictors of a lower EQ
VAS score but only depression had a negative effect on the
SF-36 MCS. Compared with the general population,
patients in general practice had a significantly lower score
in each scale or summary score of the SF-36, while no dif-
ference was found in the proportion of respondents
reporting any problem in the self-care dimension of the
EQ-5D.
The associations between demographic variables and the
HRQol were generally in line with literature. Self-reported
severe illness experience is predictive for worse HRQoL.
Old age is indicative of worse physical health and better
mental health [18,20,35,36]. Patients not living with a
partner reported worse HRQoL [18,20,35,36]. Educa-
tional attainment was associated with better HRQol
[18,20,36], and unemployment was associated with
poorer levels of HRQol [18,24,37]. Experience of illness
of a family member had adverse effects on HRQoL
[38,39], which was not observed in our study. Our study
had a cross-sectional design, so it was not possible to
determine causal relationships. Further longitudinal stud-
ies in the primary care setting will be required to test for
the presence of associations between these demographics
and the HRQoL and to fully interpret their clinical signif-
icance.
Limitations of the study
The study reported here is part of a project to make a cross-
cultural comparison of HRQoL for patients consulting in
Table 7: Regression models for the SF-36 summary scores and the EQ VAS score using the age polynomials
Variables PCSa MCSb EQ VASc
βd(SE)e P value βd(SE)e P value βd(SE)e P value
Age in years -0.219(0.022) <0.001 -1.210(0.503) 0.016 0.514(0.232) 0.027
Age squared 0.031(0.011) 0.005 -0.007(0.002) 0.006
Age cubed <0.001 (<0.001) 0.003
Constant 55.459(1.091) <0.001 57.971(7.124) <0.001 61.367(5.216) <0.001
F value 99.931 <0.001 12.104 <0.001 7.421 0.001
R-square 0.110 0.043 0.019
a PCS: physical component summary score.
b MCS: mental component summary score.
c EQ VAS: EQ-5D visual analogue scale.
d Regression coefficient (linear or non-linear relationship).
e SE = standard error.BMC Public Health 2008, 8:246 http://www.biomedcentral.com/1471-2458/8/246
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general practice between Germany and China. The study
included more than 1000 patients. We could only use a
convenience sample of general practices, but as the obser-
vation unit was the patient, we were confident that neither
the regional limits nor the specificity of the study practices
would substantially constrain the sample. The practices
were basically comparable to the region. Of course, our
survey is not easily comparable to other countries, as the
"ecology" of primary care differs in every health care sys-
tem.
There is difference between the HRQoL for general prac-
tice population and those for "stable" patients in the com-
munity. It is more salient for some diseases than others.
For example, patients with back pain as their reason for
encounter were likely to have worse pain and role limita-
tions, whereas patients with hypertension as their reason
for encounter saw the doctor probably for regular pre-
scription and check. There is a bias with consecutive visit-
based sampling: practice population has very different
contact frequencies and thus more frequent users (likely
to be sicker patients) are selected which will bias the asso-
ciations in the direction of their own profile [40]. Our
study might not generalize to the low users of general
practice. Each practice was asked to complete 50 question-
naires. We would suppose they needed only two or three
days to collect the questionnaires. Therefore the risk that
one patient was questioned more than once seems negli-
gible. However, we could not assume that there was no
clustering of patient by practice. It remains a limitation.
Home visit patients were not included. Non-respondents
seemed to be older, which might lead to underestimation
of the prevalence of morbidity and consequently influ-
ence the HRQoL of this population.
The number of patients with specific diseases such as pol-
yarthritis was insufficient, which led to difficulties in
showing a statistical significance for smaller effects. This
suggests the possibility of false negative results (type II
error). We performed a large number of hypothesis tests,
which suggests the possibility of false positive results
(type I error). The absence or presence of chronic diseases
in our research sample was recorded by the doctors, which
could preclude the possibility of confounding due to per-
sonal or mood characteristics [8]. However, we did not
assess the severity of each condition, which may explain
why the multivariable models did not account for a larger
proportion of the variability in HRQoL scores (R-square
17.5 to 25.6% for linear regression models). Fortin et al.
used the Cumulative Illness Rating Scale (CIRS) as a meas-
ure of disease severity in a primary care context, and
revealed a stronger association with the HRQoL [23].
Conclusion
This study indicated that general practice patients with
differing chronic diseases in Germany had impaired qual-
ity of life compared with patients without chronic condi-
tions and the general population, especially in terms of
physical health. We found that OA of the knee and back
pain predicted of a lower SF-36 PCS score, depression pre-
dicted of a lower SF-36 MCS score, and that depression
and cancer were risk factors for the EQ VAS score. Findings
from this study might help health professionals to con-
cern more influential diseases in primary care from the
patient's perspective. Further research is needed to iden-
tify the clinically important differences in HRQoL scores
for primary care patients with differing chronic diseases.
This research should also be done in patient samples rep-
resentative of both high and low users of general practice,
so that results may generalize to the broader practice pop-
ulation. Independent influences of both disease type and
severity on the HRQoL need to be observed. Additionally,
to determine causal relationships, further longitudinal
studies in the primary care setting will be needed to test
for the associations between the demographics and the
HRQoL.
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